These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11442207)

  • 1. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.
    Lolekha S; Tanthiphabha W; Sornchai P; Kosuwan P; Sutra S; Warachit B; Chup-Upprakarn S; Hutagalung Y; Weil J; Bock HL
    Am J Trop Med Hyg; 2001; 64(3-4):131-6. PubMed ID: 11442207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
    Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of varicella-zoster virus in Korea.
    Lee H; Cho HK; Kim KH
    J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate.
    O'Grady KA; Merianos A; Patel M; Gilbert L
    Trop Med Int Health; 2000 Oct; 5(10):732-6. PubMed ID: 11044268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.
    Rimseliene G; Vainio K; Gibory M; Salamanca BV; Flem E
    BMC Infect Dis; 2016 Jun; 16():254. PubMed ID: 27266273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
    Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
    Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster and fever rash surveillance in Lao People's Democratic Republic.
    Nouanthong P; Hübschen JM; Billamay S; Mongkhoune S; Vilivong K; Khounvisith V; Sinner R; Grandadam M; Phonekeo D; Black AP; Muller CP
    BMC Infect Dis; 2019 May; 19(1):392. PubMed ID: 31068140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions].
    Reis AD; Pannuti CS; de Souza VA
    Rev Soc Bras Med Trop; 2003; 36(3):317-20. PubMed ID: 12908030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea.
    Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW
    Int J Infect Dis; 2008 May; 12(3):245-7. PubMed ID: 17950022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.
    Perez-Farinos N; Garcia-Comas L; Ramirez-Fernandez R; Sanz JC; Barranco D; Garcia-Fernandez C; Ordobas M
    Cent Eur J Public Health; 2008 Mar; 16(1):41-4. PubMed ID: 18459480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore.
    Fatha N; Ang LW; Goh KT
    Int J Infect Dis; 2014 May; 22():73-7. PubMed ID: 24269652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico.
    Alvarez y Muñoz MT; Torres J; Damasio-Santana L; Gómez A; Fernández-Quintanilla G; Tapia-Conyer R; Muñoz O
    Arch Med Res; 1999; 30(1):60-3. PubMed ID: 10071427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.
    Dayan GH; Panero MS; Debbag R; Urquiza A; Molina M; Prieto S; Del Carmen Perego M; Scagliotti G; Galimberti D; Carroli G; Wolff C; Schmid DS; Loparev V; Guris D; Seward J
    J Clin Microbiol; 2004 Dec; 42(12):5698-704. PubMed ID: 15583301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of varicella-zoster in Pakistan.
    Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia.
    Bartoloni A; Bartalesi F; Roselli M; Mantella A; Dini F; Carballo ES; Barron VP; Paradisi F
    Trop Med Int Health; 2002 Jun; 7(6):512-7. PubMed ID: 12031073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.